logo

[breadcrumb_custom]

XLO’s Stock Journey: What Investors Need to Know About Xilio Therapeutics Inc’s Performance

Xilio Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $3.67 on 04/12/23, and the lowest price during that time was $0.49, recorded on 12/20/23.

52-week price history of XLO Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Xilio Therapeutics Inc’s current trading price is -61.72% away from its 52-week high, while its distance from the 52-week low is 186.73%. The stock’s price range for this period has remained between $0.49 and $3.67. The Healthcare sector company’s shares managed to surpass a trading volume of around 16.34 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.78 million over the last three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Financial Performance and Market Capitalization

Xilio Therapeutics Inc (XLO) has experienced a quarterly rise of 146.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 38.69M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8213, with a change in price of -0.9499. Similarly, Xilio Therapeutics Inc recorded 669,074 in trading volume during the last 100 days, posting a change of -39.58%.

XLO Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for XLO stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.16.

XLO Stock Stochastic Average

As of today, the raw stochastic average of Xilio Therapeutics Inc over the last 50 days is at 66.44%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 64.45%. Further, the company’s Stochastic %K and %D values for the last 20 days were 46.18% and 33.54%, respectively.

XLO Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 155.45% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -34.95%. Over the past 30 days, the price of XLO has fallen by 98.17%. And in the last five days, it has surged by 98.59%.

On Key

Related Posts